• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

Monthly Archives: June 2017

Interview about EPAD by Touch Neurology

On June 24-27, the third Congress of the European Academy of Neurology (EAN) took place in Amsterdam. The congress gathered more than 6,000 neurologists from all over Europe and the…

2017-06-27NewsBy EPAD Administrator3

CITA Foundation enrols its first participant

We are very pleased to announce that the EPAD LCS study is now recruiting volunteers in San Sebastian (Spain), which opened as a new EPAD Trial Delivery Center. This centre…

2017-06-27NewsBy EPAD Administrator3

EPAD project launches its Academy

On 15 June, the European Prevention of Alzheimer’s Dementia (EPAD) project announced the launch of its EPAD Academy that is aiming to efficiently leverage EPAD resources to foster and develop…

2017-06-15EPAD Academy, NewsBy EPAD Administrator3

EPAD is acknowledged in a JAMA editorial

On 13 June, the Journal of the American Medical Association (JAMA) published an editorial entitled “Brain Amyloid Pathology and Cognitive Function – Alzheimer Disease Without Dementia?”. This paper was written…

2017-06-13NewsBy EPAD Administrator3

Interview with the IMI Programme Office

The EPAD project has an ambitious goal – to revolutionise the way we carry out clinical trials for treatments designed to prevent Alzheirmer’s dementia. In a interview with the IMI…

2017-06-06NewsBy EPAD Administrator3
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT